AD5-NCOV for alzheimer disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 3 registered trials.

Why this status

  1. 26 Aug 2020: Trial registered, NCT04526990
  2. 15 Sep 2020: Trial started, NCT04526990

The trials

NCT04566770: A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)

State
Completed
Phase
Phase 2
People
480 taking part
Started
24 Sep 2020
Primary completion
21 Sep 2021
Arms
MID A, MIN A, OLD A, OLD B, EBOV A
Results
None posted
Papers
doi:10.1080/21645515.2023.2230760, doi:10.1093/cid/ciab845
  1. 24 Sep 2020: Trial started
  2. 28 Sep 2020: Trial registered
  3. 19 Jan 2022: Trial completed

NCT04916886: A Clinical Trial of Immunobridging and Lot-to-lot Consistency of COVID-19 Vaccine (Ad5-nCoV) in Different Age Groups.

State
Completed
Phase
No phase
People
2,021 taking part
Started
3 Jun 2021
Primary completion
31 Jul 2022
Arms
50L Scale (Age 18-59), 500L Scale (Age 18-59), 800L Scale (Age 18-59), 800L Scale Lot 1 (Age 13-17), 800L Scale Lot 2 (Age 13-17), 800L Scale Lot 3 (Age 13-17), 800L Scale Lot 1 (Age 6-12), 800L Scale Lot 2 (Age 6-12), 800L Scale Lot 3 (Age 6-12)
Results
None posted
Papers
doi:10.1080/14760584.2023.2234997
  1. 3 Jun 2021: Trial started
  2. 8 Jun 2021: Trial registered
  3. 31 Jul 2022: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Also known as Ad5-nCoV-IH, Ad5-nCoV-IM, Aerosolized Ad5-nCoV, Bivalent Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector), Convidicea, High dose aerosolized Ad5-nCoV, Intramuscularly administered Ad5-nCoV vaccine, Low dose aerosolized Ad5-nCoV, Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.3ml, Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml, Recombinant SARS-CoV-2 Ad5 vectored vaccine.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.